Related Experiment Video
Updated: Jun 26, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Development of Personalized Strategies for Precisely Battling Malignant Melanoma
Armond J Isaak1, GeGe R Clements1, Rand Gabriel M Buenaventura1
1Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Melanoma is the most severe and fatal form of skin cancer, resulting from multiple gene mutations with high intra-tumor and inter-tumor molecular heterogeneity. Treatment options for patients whose disease has progressed beyond the ability for surgical resection rely on currently accepted standard therapies, notably immune checkpoint inhibitors and targeted therapies. Acquired resistance to these therapies and treatment-associated toxicity necessitate exploring novel strategies, especially those that can be personalized for specific patients and/or populations. Here, we review the current landscape and progress of standard therapies and explore what personalized oncology techniques may entail in the scope of melanoma. Our purpose is to provide an up-to-date summary of the tools at our disposal that work to circumvent the common barriers faced when battling melanoma.
Insights
Melanoma, a deadly skin cancer, presents treatment challenges due to resistance and toxicity. This review explores standard therapies and emerging personalized oncology strategies to overcome these barriers.
Area of Science:
- Oncology
- Dermatology
- Genetics
Background:
- Melanoma is a severe skin cancer with significant molecular heterogeneity.
- Standard treatments like immune checkpoint inhibitors and targeted therapies are used for advanced melanoma.
- Resistance and toxicity limit the effectiveness of current melanoma treatments.
Purpose of the Study:
- To review the current landscape of standard melanoma therapies.
- To explore personalized oncology techniques for melanoma treatment.
- To summarize tools for overcoming barriers in melanoma management.
Main Methods:
- Literature review of standard melanoma therapies.
- Exploration of personalized oncology approaches.
- Synthesis of current research on melanoma treatment strategies.
Main Results:
- Standard therapies (immune checkpoint inhibitors, targeted therapies) have limitations.
- Acquired resistance and toxicity are significant challenges.
- Personalized oncology offers potential novel strategies.
Conclusions:
- Novel strategies are needed to address resistance and toxicity in melanoma.
- Personalized oncology holds promise for tailored melanoma treatment.
- An updated understanding of available tools is crucial for effective melanoma management.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Survival Analysis

